Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Viral Load–Guided Immunosuppression After Lung Transplantation
2019-001770-29Phase 3Completed
- Sponsor
- Philipps-Universität Marburg
- Start
- May 2019
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of tacrolimus in Lung allograft rejection (LAR) (2 arms), sponsored by Philipps-Universität Marburg. Primary endpoint: Primary efficacy endpoint ΔGFR. Started May 2019; status: completed.
02
Drugs
tacrolimus
03
Conditions
Lung allograft rejection (LAR)
Beyond the preview
Go deeper on 2019-001770-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001770-29.